| 英文名称 |
中文名称 |
CAS |
|
9-cis-Retinyl palmitate
|
|
34356-29-1 |
|
5-(Bromomethyl)-4-iodo-1-methyl-1H-pyrazole hydrobromide
|
|
2126178-39-8 |
|
1,2-Benzothiazol-6-ol
|
|
934180-38-8 |
|
(2S)-2-(2-Acetamidoacetamido)-3-(4-hydroxyphenyl)propanoic acid
|
|
84794-59-2 |
|
1-Ethyl-5-(trifluoromethyl)-1H-pyrazol-3-amine
|
|
1169994-43-7 |
|
2-Bromo-6-(tert-butoxy)pyridine
|
|
949160-14-9 |
|
[3-(Piperidin-1-ylmethyl)phenyl]methanamine dihydrochloride
|
|
1431965-80-8 |
|
NAPG antibody
|
|
|
|
3'-Azido-N6-benzoyl-2'-O-tert-butyldimethylsilyl-5'-O-DMT-adenosine
|
|
|
|
2-(4-Bromophenyl)-1-cyclobutylethan-1-one
|
|
1183705-75-0 |
|
3-Chloro-4'-hydroxybenzophenone
|
|
61002-52-6 |
|
Fluoxastrobin-d4
|
|
1246833-67-9 |
|
rac-2-[(2R,6R)-6-Methylpiperidin-2-yl]ethan-1-ol
|
|
1354392-55-4 |
|
2,3-Dichloro-6-nitroaniline
|
|
65078-77-5 |
|
1,1-Bis-(methylthio)-2-nitroethene
|
|
13623-94-4 |
|
PIN1 antibody
|
|
|
|
(S)-2-((4-Chlorophenyl)(piperidin-4-yloxy)methyl)pyridine (2R,3R)-2,3-dihydroxysuccinate ee
|
|
210095-58-2 |
|
Recombinant Human PF-4
|
|
|
|
2,2-Difluoroethanimidamide hydrochloride
|
|
1152109-97-1 |
|
Bz-Val-Gly-Arg-pNA hydrochloride salt
|
|
64717-41-5 |
|
[1-(2-Amino-6-chloropyrimidin-4-yl)pyrrolidin-2-yl]methanol
|
|
1494756-17-0 |
|
4-Methylumbelliferyl b-D-glucuronide hydrate
|
|
881005-91-0 |
|
ARQ 531
|
|
2095393-15-8 |
|
1-(2-Methylpyridin-3-yl)ethanone
|
|
1721-12-6 |
|
H-NPQLCYQDTILWK^-OH
|
|
|
|
1H,1H,2H,2H-Tridecafluoro-1-n-octanol
|
|
647-42-7 |
|
4-Ethynylcyclohexan-1-amine hydrochloride
|
|
1803593-39-6 |
|
H-DGGAWGTEQR-OH
|
|
|
|
SCH 58261
|
|
160098-96-4 |
|
2-bromo-3,5-dimethylphenol
|
|
125237-08-3 |
|
4-Methoxy-2,3-dihydro-1H-inden-2-amine
|
|
76413-92-8 |
|
CCK-Tetrapeptide (30-33)
|
|
5609-49-4 |
|
5-Bromo-2-methyl-2,3-dihydro-1-benzofuran
|
|
102292-30-8 |
|
H-Gly-His-Arg-Pro-OH acetate salt
|
|
67869-60-7 |
|
1-(Chloromethyl)-3-(2-methylpropoxy)benzene
|
|
1036486-25-5 |
|
C11orf73 antibody
|
|
|
|
H-EIQTAVR^-OH
|
|
|
|
Flavan
|
|
494-12-2 |
|
1-[4-(2,2-Difluoroethanesulfonyl)phenyl]ethan-1-one
|
|
1354952-58-1 |
|
2-(Methylamino)-2-[4-(trifluoromethyl)phenyl]acetic acid hydrochloride
|
|
1375471-43-4 |
|
3-Bromo-3-buten-1-ol
|
|
76334-36-6 |
|
S130
|
|
1160852-22-1 |
|
(1-Aminocyclobut-1-yl)acetic acid, N-BOC protected
|
|
249762-02-5 |
|
N,N-Bis(2-hydroxyethyl)dodecanamide
|
|
120-40-1 |
|
IGFBP7 antibody
|
|
|
|
4-Chloro-6-methylnicotinic acid
|
|
1060805-95-9 |
|
Escitalopram
|
|
128196-01-0 |
|
3-(Pyridin-3-yl)cyclohexan-1-one
|
|
192717-48-9 |
|
OR2T5 antibody
|
|
|
|
4-chloro-1-((4-(3-phenylprop-2-enyl)piperazinyl)sulfonyl)benzene
|
|
1049983-71-2 |
|
Astragaloside I
|
|
84680-75-1 |
|
3',4'-O-Carbonyl-6,6'-di-O-tert-butyldimethylsilyl lactal
|
|
163228-39-5 |
|
4-Trifluoromethylphenyl hydrazine hydrochloride
|
|
2923-56-0 |
|
Panipenem
|
|
87726-17-8 |
|
2-{[4-(Piperidin-1-yl)phenyl]sulfamoyl}acetic acid
|
|
1098369-40-4 |
|
3-(4-Bromophenyl)-3-methylazetidine trifluoroacetate
|
|
2044744-62-7 |
|
3,3-Dimethyl-3,4-dihydro-2H-pyran-4-one
|
|
625099-32-3 |
|
H-PCVKLTPLCVTLNCT-OH
|
|
|
|
N-Lauroyl-L-glutamic acid
|
|
3397-65-7 |
|
5-Bromo-4-methylthiophene-2-carboxylic acid
|
|
54796-53-1 |
|
Methyl 3-[(2-methoxy-2-oxoethyl)sulfanyl]butanoate
|
|
78648-41-6 |
|
tert-Butyl (4R-cis)-6-formaldehydel-2,2-dimethyl-1,3-dioxane-4-acetate
|
|
124752-23-4 |
|
1-[2-(Trifluoromethyl)benzenesulfonyl]piperazine
|
|
565192-03-2 |
|
2-(3-Bromophenyl)pentan-3-amine
|
|
1481856-80-7 |
|
9-Epi-cinchonidine
|
|
550-54-9 |
|
2-Amino-5-fluoro-N,N-dimethylbenzamide hydrochloride
|
|
1803583-95-0 |
|
3,4-Dichlorobenzene-1-carboximidamide hydrochloride
|
|
50292-25-6 |
|
2-Iodo-2,3-dihydro-1H-indene
|
|
24329-96-2 |
|
4-(6-Amino-1,2-dihydroquinoxalin-2-ylidene)cyclohexa-2,5-dien-1-one
|
|
1215165-42-6 |
|
5-Bromo-2-fluoro-1-nitro-3-(trifluoromethyl)benzene
|
|
889459-12-5 |
|
H-LCVQSTHVD-OH
|
|
|
|
3-Methoxy-5-methylpyridine-2-carboxylic acid
|
|
1256795-11-5 |
|
2-[1-(2-Methylpropyl)-1H-pyrazol-3-yl]acetic acid
|
|
1782284-08-5 |
|
2'-Deoxy-8-oxo-6-thioguanosine 5'-triphosphate
|
|
|
|
5,6,7,8-Tetrahydroquinoline-8-carboxylic acid hydrochloride
|
|
1795283-34-9 |
|
Yohimbine hydrochloride
|
|
65-19-0 |
|
N,N'-Diphenyl-2-(phenylamino)ethanimidamide
|
|
14181-81-8 |
|
1H-1,2,4-Triazol-5-ylboronic acid
|
|
1219080-60-0 |
|
3-Methyl-5-(tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde
|
|
1392146-21-2 |
|
Fluor-QEDIIRNIARHLAQVGDSMDR-OH
|
|
|
|
5-Iodo-2,3-dimethoxybenzoic acid
|
|
134419-42-4 |
|
Ginsenoside Rc
|
|
11021-14-0 |
|
Ethyl-(1-methyl-pyrrolidin-3-yl)-amine
|
|
1096325-56-2 |
|
HPDL Blocking Peptide
|
|
|
|
4-Aminopyridin-1-ium-1-olate hydrochloride
|
|
1433-03-0 |
|
3-Chloro-4-(4-chlorophenoxy)benzoic acid
|
|
1384431-04-2 |
|
1-N-Boc-4-bromopiperidine
|
|
180695-79-8 |
|
4,4,5,5-Tetramethyl-2-[(phenylsulfanyl)methyl]-1,3,2-dioxaborolane
|
|
66080-23-7 |
|
2-(2,6-Dichlorophenyl)propanoic acid
|
|
2012-78-4 |
|
5-Methyl-1-{[4-(trifluoromethyl)phenyl]methyl}-1H-1,2,3-triazole-4-carboxylic acid
|
|
1111881-70-9 |
|
Methyl 2-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylate
|
|
314279-09-9 |
|
4-Undecyloxybenzoic acid
|
|
15872-44-3 |
|
4-Bromo-1H-benzimidazole-6-carbonitrile
|
|
1360921-11-4 |
|
2-fluoro-5-hydroxybenzaldehyde
|
|
103438-84-2 |
|
Methyl 2-(2-amino-1,3-benzothiazol-6-yl)acetate
|
|
99738-99-5 |
|
Chloroquine N-oxide
|
|
68121-48-2 |
|
{4-[(2-Methylpropyl)amino]piperidin-4-yl}methanol dihydrochloride
|
|
1864061-11-9 |
|
2-(Iodomethyl)-5-methyloxolane
|
|
19056-49-6 |
|
ZCL 278
|
|
587841-73-4 |
|
H-SPLAGYTSVIR-OH
|
|
|
